Adverse effects of induced hot flashes on objectively recorded and subjectively reported sleep: Results of a gonadotropin-releasing hormone agonist experimental protocol

Menopause

Volumn 20, Issue 9, 2013, Pages 905-914

  Joffe, Hadine ^a   White, David P ^b   Crawford, Sybil L ^c   McCurnin, Kristin E ^a   Economou, Nicole ^a   Connors, Stephanie ^a   Hall, Janet E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Depressive symptoms; Hot flashes; Quality of life; Sleep; Vasomotor symptoms

Indexed keywords

ESTRADIOL; ESTRONE; FOLLITROPIN; LEUPRORELIN; LUTEINIZING HORMONE; GONADORELIN;

ACTIMETRY; ADULT; ADVERSE OUTCOME; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; EPWORTH SLEEPINESS SCALE; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HOT FLUSH; HUMAN; INSOMNIA; PITTSBURGH SLEEP QUALITY INDEX; POLYSOMNOGRAPHY; PREMENOPAUSE; QUALITY OF LIFE; SKIN CONDUCTANCE; SLEEP DISORDER; SLEEP PATTERN; SLEEP QUALITY; WAKEFULNESS; AGONISTS; CHEMICALLY INDUCED; CIRCADIAN RHYTHM; COMPLICATION; CONTROLLED CLINICAL TRIAL; DRUG EFFECTS; ELECTRODERMAL RESPONSE; METABOLISM; MIDDLE AGED; NORMAL HUMAN; PHYSIOLOGY; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; WOMEN'S HEALTH;

ADULT; CIRCADIAN RHYTHM; ESTRADIOL; FEMALE; FOLLOW-UP STUDIES; GALVANIC SKIN RESPONSE; GONADOTROPIN-RELEASING HORMONE; HEALTHY VOLUNTEERS; HOT FLASHES; HUMANS; MIDDLE AGED; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; WOMEN'S HEALTH;

EID: 84883654730     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/GME.0b013e31828292d1     Document Type: Article

References (62)

1. Kravitz HM, Ganz PA, Bromberger J, Powell LH, Sutton-Tyrrell K, Meyer PM. Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. Menopause 2003;10:19-28.
2. Woods NF, Mitchell ES. Sleep symptoms during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Sleep 2010;33:539-549.
3. Ohayon MM. Severe hot flashes are associated with chronic insomnia. Arch Intern Med 2006;166:1262-1268.
4. Thurston RC, Santoro N, Matthews KA. Are vasomotor symptoms associated with sleep characteristics among symptomatic midlife women? Comparisons of self-report and objective measures. Menopause 2012;19: 742-748.
5. Freedman RR, Roehrs TA. Sleep disturbance in menopause. Menopause 2007;14:826-829.
6. Kravitz HM, Zhao X, Bromberger JT, et al. Sleep disturbance during the menopausal transition in a multi-ethnic community sample of women. Sleep 2008;31:979-990.
7. Burleson MH, Todd M, Trevathan WR. Daily vasomotor symptoms, sleep problems, and mood: using daily data to evaluate the domino hypothesis in middle-aged women. Menopause 2010;17:87-95.
8. Young T, Rabago D, Zgierska A, Austin D, Laurel F. Objective and subjective sleep quality in premenopausal, perimenopausal, and postmenopausal women in the Wisconsin Sleep Cohort Study. Sleep 2003;26: 667-672.
9. Ensrud KE, Stone KL, Blackwell TL, et al. Frequency and severity of hot flashes and sleep disturbance in postmenopausal women with hot flashes. Menopause 2009;16:286-292.
10. Thurston RC, Blumenthal JA, Babyak MA, Sherwood A. Association between hot flashes, sleep complaints, and psychological functioning among healthy menopausal women. Int J Behav Med 2006;13:163-172.
11. Shaver J, Giblin E, Lentz M, Lee K. Sleep patterns and stability in perimenopausal women. Sleep 1988;11:556-561.
12. Erlik Y, Tataryn IV, Meldrum DR, Lomax P, Bajorek JG, Judd HL. Association of waking episodes with menopausal hot flushes. JAMA 1981;245:1741-1744.
13. Savard J, Davidson JR, Ivers H, et al. The association between nocturnal hot flashes and sleep in breast cancer survivors. J Pain Symptom Manage 2004;27:513-522.
14. Woodward S, Freedman RR. The thermoregulatory effects of menopausal hot flashes on sleep. Sleep 1994;17:497-501.
15. Freedman RR, Benton MD, Genik RJ II, Graydon FX. Cortical activation during menopausal hot flashes. Fertil Steril 2006;85:674-678.
16. Freedman RR, Roehrs TA. Lack of sleep disturbance from menopausal hot flashes. Fertil Steril 2004;82:138-144.
17. Carpenter JS, Newton KM, Sternfeld B, et al. Laboratory and ambulatory evaluation of vasomotor symptom monitors from the Menopause Strategies Finding Lasting Answers for Symptoms and Health network. Menopause 2012;19:664-671.
18. Hunter MS, Haqqani JR. An investigation of discordance between subjective and physiological measures of vasomotor symptoms. Climacteric 2011;14:146-151.
19. Thurston RC, Blumenthal JA, Babyak MA, Sherwood A. Emotional antecedents of hot flashes during daily life. PsychosomMed 2005;67: 137-146.
20. Baker FC, Sassoon SA, Kahan T, et al. Perceived poor sleep quality in the absence of polysomnographic sleep disturbance in women with severe premenstrual syndrome. J Sleep Res 2012;21:535-545.
21. Bei B, Milgrom J, Ericksen J, Trinder J. Subjective perception of sleep, but not its objective quality, is associated with immediate postpartum mood disturbances in healthy women. Sleep 2010;33:531-538.
22. Okifuji A, Hare BD. Nightly analyses of subjective and objective (actigraphy) measures of sleep in fibromyalgia syndrome: what accounts for the discrepancy? Clin J Pain 2011;27:289-296.
23. Avis NE, Colvin A, Bromberger JT, et al. Change in health-related quality of life over the menopausal transition in a multiethnic cohort of middle-aged women: Study of Women's Health Across the Nation. Menopause 2009;16:860-869.
24. WoodsNF, Smith-DiJulio K, Percival DB, Tao EY,Mariella A,Mitchell S. Depressed mood during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause 2008;15:223-232.
25. Joffe H, Hall J, Soares C, et al. Vasomotor symptoms are associated with depression in perimenopausal women seeking primary care. Menopause 2002;9:392-398.
26. Freeman EW, Sammel MD, Liu L, Gracia CR, Nelson DB, Hollander L. Hormones and menopausal status as predictors of depression in women in transition to menopause. Arch Gen Psychiatry 2004;61:62-70.
27. Bromberger JT, Schott LL, Kravitz HM, et al. Longitudinal change in reproductive hormones and depressive symptoms across the menopausal transition: results from the Study of Women's Health Across the Nation (SWAN). Arch Gen Psychiatry 2010;67:598-607.
28. Joffe H, Petrillo LF, Koukopoulos A, et al. Increased estradiol and improved sleep, but not hot flashes, predict enhanced mood during the menopausal transition. J Clin Endocrinol Metab 2011;96:E1044-E1054.
29. Takeuchi H, Kobori H, Kikuchi I, Sato Y, Mitsuhashi N. A prospective randomized study comparing endocrinological and clinical effects of two types of GnRH agonists in cases of uterine leiomyomas or endometriosis. J Obstet Gynaecol Res 2000;26:325-331.
30. Tanaka T. Effects of herbal medicines on menopausal symptoms induced by gonadotropin-releasing hormone agonist therapy. Clin Exp Obstet Gynecol 2001;28:20-23.
31. DeFazio J, Meldrum DR, Laufer L, et al. Induction of hot flashes in premenopausal women treated with a long-acting GnRH agonist. J Clin Endocrinol Metab 1983;56:445-448.
32. Blamey RW, Jonat W, Kaufmann M, Bianco AR, Namer M. Goserelin depot in the treatment of premenopausal advanced breast cancer. Eur J Cancer 1992;28:810-814.
33. Fellowes D, Fallowfield LJ, Saunders CM, Houghton J. Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for Fwell-tolerated-treatments? Breast Cancer Res Treat 2001;66:73-81.
34. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a selfreport version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-1744.
35. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389.
36. Davidson J, Turnbull CD, Strickland R, Miller R, Graves K. The Montgomery-Asberg Depression Scale: reliability and validity. Acta Psychiatr Scand 1986;74:544-548.
37. Rudd MD, Rajab MH. Specificity of the Beck Depression Inventory and the confounding role of comorbid disorders in a clinical sample. Cogn Ther Res 1995;19:51-68.
38. San Roman GA, Surrey ES, Judd HL, Kerin JF. A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in vitro fertilization. Fertil Steril 1992;58:744-749.
39. Meldrum DR, Wisot A, Hamilton F, Gutlay AL, Huynh D, Kempton W. Timing of initiation and dose schedule of leuprolide influence the time course of ovarian suppression. Fertil Steril 1988;50: 400-402.
40. Gelety TJ, Pearlstone AC, Surrey ES. Short-term endocrine response to gonadotropin-releasing hormone agonist initiated in the early follicular, midluteal, or late luteal phase in normally cycling women. Fertil Steril 1995;64:1074-1080.
41. West CP, Baird DT. Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue. Clin Endocrinol (Oxf) 1987;26:213-220.
42. Carpenter JS, Andrykowski MA, Freedman RR, Munn R. Feasibility and psychometrics of an ambulatory hot flash monitoring device. Menopause 1999;6:209-215.
43. Freedman RR. Laboratory and ambulatory monitoring of menopausal hot flashes. Psychophysiology 1989;26:573-579.
44. Buysse DJ, Reynolds CFD, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
45. Lewis JE, Hilditch JR, Wong CJ. Further psychometric property development of the Menopause-Specific Quality of Life Questionnaire and development of a modified version, MENQOL-Intervention questionnaire. Maturitas 2005;50:209-221.
46. Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 1991;14:540-545.
47. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
48. Nelson RE, Grebe SK, Okane DJ, Singh RJ. Liquid chromatographyY tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma. Clin Chem 2004;50:373-384.
49. Siekmann L. Determination of oestradiol-17A in human serum by isotope dilutionYmass spectrometry. Definitive methods in clinical chemistry, II. J Clin Chem Clin Biochem 1984;22:551-557.
50. Welt CK, Pagan YL, Smith PC, Rado KB, Hall JE. Control of folliclestimulating hormone by estradiol and the inhibins: critical role of estradiol at the hypothalamus during the luteal-follicular transition. J Clin Endocrinol Metab 2003;88:1766-1771.
51. Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab 1999;84:105-111.
52. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000;355:1064-1069.
53. Germain A, Moul DE, Franzen PL, et al. Effects of a brief behavioral treatment for late-life insomnia: preliminary findings. J Clin Sleep Med 2006;2:403-406.
54. Woodward S, Arfken CL, Ditri DW, Freedman RR. Ambient temperature effects on sleep and mood in menopausal women. Sleep 1999;22(Suppl 1): S224-S225.
55. Freedman RR. Biochemical, metabolic, and vascular mechanisms in menopausal hot flashes. Fertil Steril 1998;70:332-337.
56. Freedman RR, Woodward S. Core body temperature during menopausal hot flushes. Fertil Steril 1996;65:1141-1144.
57. Carpenter JS, Gilchrist JM, Chen K, Gautam S, Freedman RR. Hot flashes, core body temperature, and metabolic parameters in breast cancer survivors. Menopause 2004;11:375-381.
58. Van Someren EJ. More than a marker: interaction between the circadian regulation of temperature and sleep, age-related changes, and treatment possibilities. Chronobiol Int 2000;17:313-354.
59. Loprinzi CL, Barton DL. Gadgets for measuring hot flashes: have they become the gold standard? J Support Oncol 2009;7:136-137.
60. Wang-Weigand S, McCue M, Ogrinc F, Mini L. Effects of ramelteon 8 mg on objective sleep latency in adults with chronic insomnia on nights 1 and 2: pooled analysis. Curr Med Res Opin 2009;25:1209-1213.
61. Sadeh A. The role and validity of actigraphy in sleep medicine: an update. Sleep Med Rev 2011;15:259-267.
62. D'Ambrosio C, Stachenfeld NS, Pisani M, Mohsenin V. Sleep, breathing, and menopause: the effect of fluctuating estrogen and progesterone on sleep and breathing in women. Gend Med 2005;2:238-245.